These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials. D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation. Hoffe S; Rao N; Shridhar R Semin Radiat Oncol; 2014 Apr; 24(2):113-25. PubMed ID: 24635868 [TBL] [Abstract][Full Text] [Related]
14. [Developments and controversies in neoadjuvant therapy for resectable pancreatic cancer]. Bai XL; Li X; Liang TB Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):486-489. PubMed ID: 32610415 [TBL] [Abstract][Full Text] [Related]
15. [Evidence for Neoadjuvant Therapy in Resectable Pancreatic Cancer]. Nießen A; Büchler MW; Hackert T Zentralbl Chir; 2022 Apr; 147(2):168-172. PubMed ID: 35378557 [TBL] [Abstract][Full Text] [Related]
16. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers. Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG; JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170 [TBL] [Abstract][Full Text] [Related]
18. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma. Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385 [TBL] [Abstract][Full Text] [Related]
19. Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma. Eid M; Ostřížková L; Kunovský L; Brančíková D; Kala Z; Hlavsa J; Janeček P; Kosíková I; Blažková M; Slabý O; Mayer J Neoplasma; 2021 Jan; 68(1):1-9. PubMed ID: 32880468 [TBL] [Abstract][Full Text] [Related]
20. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]